Contact us
Innovation
Company
Therapeutic areas
Investors
News
Media & Publications
Career
Contact
Verigraft
Arvid Wallgrens Backe 20
41346 Gothenburg
Sweden
info@verigraft.com
Home
/
News
/
VERIGRAFT was selected as a finalist…
News
Published: April 8, 2021
VERIGRAFT was selected as a finalist in the 2021 Lyfebulb-CSL Behring Innovation Challenge
Lyfebulb Challenge
Latest news
See all news
News
Published: July 3, 2026
VERIGRAFT Q2 2026 – Advancing Clinical Execution
News
Published: June 24, 2026
VERIGRAFT and BBG Advanced Therapies collaborate on P-TEV U.S. readiness
News
Published: May 28, 2026
VERIGRAFT and TFS HealthScience partner on pivotal Phase II/III trial of personalized tissue-engineered vein for chronic venous insufficiency
News
Published: May 13, 2026
VERIGRAFT Receives CTA Approval for Phase II/III Study of P-TEV
News
Published: May 7, 2026
VERIGRAFT Q1 2026 – Continued Clinical Progress
Published: April 20, 2026
VERIGRAFT Selected as Finalist in Health Tech Award 2026